[
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "summary": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=3883bd2904050fe1e68129aa5793b497f9ca296c47252a797441ca777760a043",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732120860,
      "headline": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "id": 131531736,
      "image": "",
      "related": "VRTX",
      "source": "MarketWatch",
      "summary": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=3883bd2904050fe1e68129aa5793b497f9ca296c47252a797441ca777760a043"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Could Be 48% Below Their Intrinsic Value Estimate",
    "summary": "Key Insights Using the 2 Stage Free Cash Flow to Equity, Vertex Pharmaceuticals fair value estimate is US$859 Current...",
    "url": "https://finnhub.io/api/news?id=7fda27a4c9f801211212554a25f1ee9e099bb821ce00d8a20f81db2b9eba169f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732104016,
      "headline": "Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Could Be 48% Below Their Intrinsic Value Estimate",
      "id": 131500640,
      "image": "https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Key Insights Using the 2 Stage Free Cash Flow to Equity, Vertex Pharmaceuticals fair value estimate is US$859 Current...",
      "url": "https://finnhub.io/api/news?id=7fda27a4c9f801211212554a25f1ee9e099bb821ce00d8a20f81db2b9eba169f"
    }
  }
]